Phospholamban p.Leu39* Cardiomyopathy Compared with Other Sarcomeric Cardiomyopathies: Age-Matched Patient Cohorts and Literature Review

MLA

Andreea Sorina Afana, et al. “Phospholamban p.Leu39* Cardiomyopathy Compared with Other Sarcomeric Cardiomyopathies: Age-Matched Patient Cohorts and Literature Review.” Journal of Cardiovascular Development and Disease, vol. 11, no. 2, Jan. 2024, p. 41. EBSCOhost, https://doi.org/10.3390/jcdd11020041.

APA

Andreea Sorina Afana, Laura Vasiliu, Radu Sascău, Robert Daniel Adam, Cristina Rădulescu, Sebastian Onciul, Eliza Cinteză, Adela Chirita-Emandi, & Ruxandra Jurcuț. (2024). Phospholamban p.Leu39* Cardiomyopathy Compared with Other Sarcomeric Cardiomyopathies: Age-Matched Patient Cohorts and Literature Review. Journal of Cardiovascular Development and Disease, 11(2), 41. https://doi.org/10.3390/jcdd11020041

Chicago

Andreea Sorina Afana, Laura Vasiliu, Radu Sascău, Robert Daniel Adam, Cristina Rădulescu, Sebastian Onciul, Eliza Cinteză, Adela Chirita-Emandi, and Ruxandra Jurcuț. 2024. “Phospholamban p.Leu39* Cardiomyopathy Compared with Other Sarcomeric Cardiomyopathies: Age-Matched Patient Cohorts and Literature Review.” Journal of Cardiovascular Development and Disease 11 (2): 41. doi:10.3390/jcdd11020041.